C7B.0
Secondary carcinoid tumors
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary carcinoid tumors are a type of neuroendocrine tumor that originates in one area of the body but spreads to other parts, forming new tumors. These are known as secondary because they develop as a consequence of the initial primary tumor. Although they share characteristics with primary carcinoid tumors, secondary tumors indicate metastasis, which can influence treatment options and prognosis. Recognizing and understanding this condition helps in managing and monitoring affected individuals effectively.
Causes & Symptoms
Clinical Causes: Spread of primary carcinoid tumors from initial sites such as the gastrointestinal tract, lungs, or other neuroendocrine organs Genetic mutations that predispose to neuroendocrine tumors Environmental factors that promote tumor growth and spread
Key Symptoms: Flushing, especially of the face and neck Diarrhea or abdominal cramping Long-lasting wheezing or breathing difficulties Unexplained weight loss Abdominal pain or discomfort Fatigue and weakness Possible heart valve damage (carcinoid syndrome)
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and specific tests to locate and characterize neuroendocrine tumors. Common diagnostic procedures include:
Treatment Protocols: Treatment approaches depend on the tumor’s size, location, extent of spread, and the patient’s overall health. Common options include:
Clinical Advice & FAQs
Billing Guidance
Is C7B.0 a billable ICD-10 code?
Yes, C7B.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C7B.0?
Clinical documentation must specify the nature of Secondary carcinoid tumors and any associated comorbidities for accurate reporting.
Cite this Clinical Reference